(ABC 6 News) — A new vaccine is being tested in the battle against childhood brain cancer. Researchers at the University of ...
Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...
Children’s Minnesota is testing the safety of a new vaccine combination to combat one of the deadliest pediatric cancers, which could give new hope for children who would otherwise typically die ...
The Peptide Synthesis market valued at US$ 0.78 Billion in 2023, is forecasted to grow at a robust CAGR of 11.7%, reaching ...
Now, researchers in a lab at the University of Minnesota, using a drug called CD200AR-L, have developed their own vaccine to ...